Upon approval from the State Food and Drug Administration of China ( SFDA ) , a multi-center randomized controlled trial was performed to study the efficacy and safety of HC-A II in kidney preservation from 2008 to 2012 , using histidine-tryptophan-ketoglutarate solution ( HTK ) as control ( HC-A , n = 137 , and HTK , n = 140 ) .